Inhibition of Cx43 expression in Cx43+/− transgenic mice or through Cx43asODN treatment in CKD models significantly reduced cell adhesion markers, monocyte infiltration and interstitial renal fibrosis [26]. This evidence concerns the gene GJA1 and chronic kidney disease.